Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 65

1.

Immunoregulation by 1,25-dihydroxyvitamin D3: basic concepts.

van Etten E, Mathieu C.

J Steroid Biochem Mol Biol. 2005 Oct;97(1-2):93-101. Epub 2005 Jul 19. Review.

PMID:
16046118
2.

Immunoregulation through 1,25-dihydroxyvitamin D3 and its analogs.

May E, Asadullah K, Zügel U.

Curr Drug Targets Inflamm Allergy. 2004 Dec;3(4):377-93. Review.

PMID:
15584887
3.

1α,25-Dihydroxyvitamin D3 and its analogs as modulators of human dendritic cells: a comparison dose-titration study.

Ferreira GB, Overbergh L, Verstuyf A, Mathieu C.

J Steroid Biochem Mol Biol. 2013 Jul;136:160-5. doi: 10.1016/j.jsbmb.2012.10.009. Epub 2012 Oct 23. Review.

PMID:
23098690
4.

1,25-Dihydroxyvitamin D3 selectively modulates tolerogenic properties in myeloid but not plasmacytoid dendritic cells.

Penna G, Amuchastegui S, Giarratana N, Daniel KC, Vulcano M, Sozzani S, Adorini L.

J Immunol. 2007 Jan 1;178(1):145-53.

5.

The coming of age of 1,25-dihydroxyvitamin D(3) analogs as immunomodulatory agents.

Mathieu C, Adorini L.

Trends Mol Med. 2002 Apr;8(4):174-9. Review.

PMID:
11927275
6.
7.
8.

1,25-Dihydroxyvitamin D3 curtails the inflammatory and T cell stimulatory capacity of macrophages through an IL-10-dependent mechanism.

Korf H, Wenes M, Stijlemans B, Takiishi T, Robert S, Miani M, Eizirik DL, Gysemans C, Mathieu C.

Immunobiology. 2012 Dec;217(12):1292-300. doi: 10.1016/j.imbio.2012.07.018. Epub 2012 Aug 1.

PMID:
22944250
10.
11.

[Vitamin D and the immune system].

Thomasset M.

Pathol Biol (Paris). 1994 Feb;42(2):163-72. Review. French.

PMID:
8090562
12.

Analogs of 1,25-dihydroxyvitamin D3 as dose-reducing agents for classical immunosuppressants.

van Etten E, Branisteanu DD, Verstuyf A, Waer M, Bouillon R, Mathieu C.

Transplantation. 2000 May 15;69(9):1932-42.

PMID:
10830234
13.

Paricalcitol (19-nor-1,25-dihydroxyvitamin D2) and calcitriol (1,25-dihydroxyvitamin D3) exert potent immunomodulatory effects on dendritic cells and inhibit induction of antigen-specific T cells.

Sochorová K, Budinský V, Rozková D, Tobiasová Z, Dusilová-Sulková S, Spísek R, Bartůnková J.

Clin Immunol. 2009 Oct;133(1):69-77. doi: 10.1016/j.clim.2009.06.011. Epub 2009 Aug 5.

PMID:
19660988
14.

1,25-Dihydroxyvitamin D3--a hormone with immunomodulatory properties.

Lemire J.

Z Rheumatol. 2000;59 Suppl 1:24-7. Review.

PMID:
10769431
15.

Immunomodulatory effects of vitamin D receptor ligands in autoimmune diseases.

Adorini L.

Int Immunopharmacol. 2002 Jun;2(7):1017-28. Review.

PMID:
12188026
16.

The vitamin D hormone and its nuclear receptor: molecular actions and disease states.

Haussler MR, Haussler CA, Jurutka PW, Thompson PD, Hsieh JC, Remus LS, Selznick SH, Whitfield GK.

J Endocrinol. 1997 Sep;154 Suppl:S57-73. Review.

17.

Suppressive effect of 1alpha,25-dihydroxyvitamin D3 on type I IFN-mediated monocyte differentiation into dendritic cells: impairment of functional activities and chemotaxis.

Gauzzi MC, Purificato C, Donato K, Jin Y, Wang L, Daniel KC, Maghazachi AA, Belardelli F, Adorini L, Gessani S.

J Immunol. 2005 Jan 1;174(1):270-6.

18.

Tolerogenic dendritic cells induced by vitamin D receptor ligands enhance regulatory T cells inhibiting allograft rejection and autoimmune diseases.

Adorini L, Penna G, Giarratana N, Uskokovic M.

J Cell Biochem. 2003 Feb 1;88(2):227-33. Review.

PMID:
12520519
19.
20.

Vitamin D differentially regulates B7.1 and B7.2 expression on human peripheral blood monocytes.

Clavreul A, D'hellencourt CL, Montero-Menei C, Potron G, Couez D.

Immunology. 1998 Oct;95(2):272-7.

Supplemental Content

Support Center